City of Baltimore accuses Janssen of delaying generics

23-05-2019

City of Baltimore accuses Janssen of delaying generics

Sean Pavone / Shutterstock.com

Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, is being sued for “unlawfully” delaying generic competition to Zytiga, its branded cancer medication.


Janssen Pharmaceutica, Zytiga, cancer, generic drugs, City of Baltimore, US District Court for the Eastern District of Virginia

LSIPR